EDIT
Editas Medicine Inc
Clinical-stage biotechnology company focused on CRISPR gene editing therapies
CUSIP: 28106W103HealthcareUS1 holder
Total Value
$14.0K
Total Shares
331
Net Share Change
+331
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$14.0K331 sharesNEW